Tag: inhalation anesthesia market share

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How is the Growth Rate of the Inhalation Anesthesia Market Estimated for 2024-2033?

The inhalation anesthesia market has shown strong growth in recent years. It is expected to increase from $1.46 billion in 2023 to $1.56 billion in 2024, growing at a CAGR of 7.1%. This growth is attributed to the rising number of surgical procedures requiring anesthesia, an aging population, the development of inhalation anesthetics, and the expansion of ambulatory surgical centers.

The inhalation anesthesia market size is expected to reach $2.14 billion in 2028, growing at a CAGR of 8.2%. Growth is attributed to rising demand for minimally invasive surgeries and increased global healthcare expenditure. Trends include technological innovations in anesthesia delivery and a shift toward eco-friendly anesthetic agents.

Claim Your Free Sample of the Global Inhalation Anesthesia Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7198&type=smp

What Key Drivers Are Propelling the inhalation anesthesia Market’s Growth?

Inhalation anesthesia is witnessing increased demand due to the rising geriatric population. The elderly, more susceptible to degenerative and chronic illnesses, undergo more surgeries and therapeutics. Administering anesthesia intravenously is often inconvenient for geriatric patients. According to the World Health Organization, the global population aged 60 and above is projected to reach 1.4 billion by 2022. The increasing geriatric population is expected to drive the demand for inhalation anesthesia during the forecast period.

What Are the Distinct Segments of the Inhalation Anesthesia Market?

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide

2) By Application: Induction, Maintenance

3) By End User: Hospitals, Ambulatory Surgical Centers

Which New Trends Are Making Waves in the 67 Market?

Companies in the inhalation anesthesia sector are innovating with products like Sedaconda to meet market demands and bolster their global position. Sedaconda is a sedation therapy administered through the Anaesthetic Conserving Device (ACD) and is approved for intensive care use. For example, in February 2022, Sedana Medical AB, a Sweden-based med tech and pharmaceutical company, introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) utilizes the Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy for intensive care settings, having received national approvals in 14 countries following European DCP approval in July 2021.

Order Now for Fast Delivery of Your Inhalation Anesthesia Market Report!

https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Which Regions Are Significant to the Growth of the Inhalation Anesthesia Market?

North America was the largest region in the inhalation anesthesia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Inhalation Anesthesia Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the inhalation anesthesia market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Inhalation Anesthesia Market Include

1. Inhalation Anesthesia Market Executive Summary

2. Inhalation Anesthesia Market Segments

3. Inhalation Anesthesia Market Size And Template Market Growth Rate

4. Key Inhalation Anesthesia Market Trends

5. Major Inhalation Anesthesia Market Drivers

……

25. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

26. Top Inhalation Anesthesia Companies

27. Inhalation Anesthesia Market Opportunities And Strategies

28. Inhalation Anesthesia Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Anesthetics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anesthetics-global-market-report

Insurance Fraud Detection Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insurance-fraud-detection-global-market-report

Global Central Nervous System Drugs Opportunities And Strategies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033
The inhalation anesthesia market has exhibited robust growth in recent years, and the momentum is set to continue. In 2023, the market size stood at $1.46 billion, projected to reach $1.56 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 7.1%. Looking ahead, the market is poised for even stronger growth, with an anticipated size of $2.14 billion in 2028, boasting a CAGR of 8.2%. Factors such as an aging population, technological innovations, and a rising demand for minimally invasive surgeries contribute to this upward trajectory.

Rising Geriatric Population Driving Growth

• Aging Population Dynamics: The increasing geriatric population is a significant driver for inhalation anesthesia market growth. The elderly are more prone to degenerative diseases and chronic illnesses, leading to a surge in surgeries and therapeutic interventions.
• Global Aging Trends: According to the World Health Organization, the global population aged 60 years and older is projected to reach 1.4 billion by 2022, compared to 1 billion in 2020. By 2030, 1 in 6 people worldwide will be aged 60 or older.
• Market Boost: The inconvenient administration of anesthesia through intravenous routes in geriatric patients enhances the demand for inhalation anesthesia, making it a crucial element in addressing the healthcare needs of the aging population.

Key Players Shaping the Market Landscape

• Industry Giants: Major companies driving the inhalation anesthesia market include Abbvie Inc., Baxter International Inc., Hikma Pharmaceuticals PLC, AstraZeneca PLC, and others.
• Diverse Offerings: These companies provide a comprehensive range of inhalation anesthetics, contributing to the market’s growth and innovation.

View More On The Inhalation Anesthesia Market Report 2024 – https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Technological Innovations in Anesthesia Delivery Systems

• End-Tidal (ET) Control Software: Major companies focus on developing innovative products like End-tidal (ET) Control software to advance anesthesia delivery. GE Healthcare Technologies Inc. received FDA pre-market approval for its ET Control software, enhancing the precision of inhalation anesthesia delivery.
• Benefits: The ET Control software streamlines workflows, reduces drug wastage, and contributes to cost savings and reduced greenhouse gas emissions in healthcare settings. It plays a vital role in maintaining end-tidal oxygen and anesthetic agent targets, ensuring precise administration.

Strategic Acquisitions and Expansion

• Dechra Pharmaceuticals Acquisition: In January 2022, Dechra Pharmaceuticals expanded its companion animal portfolio by acquiring Isoflurane and Sevoflurane Inhalant Anesthetics from Halocarbon Life Sciences. This strategic move enhances Dechra’s offerings in endocrinology, anesthesia, fluid therapy, and other veterinary pharmaceutical segments.
• Global Impact: The acquisition positions Dechra Pharmaceuticals as a key player in the supply of isoflurane and sevoflurane inhalation anesthetics, catering to both human and veterinary applications.

Market Segmentation for Comprehensive Insights
The inhalation anesthesia market is segmented based on various factors:

1. Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2. Application: Induction, Maintenance
3. End User: Hospitals, Ambulatory Surgical Centers

Regional Dynamics: North America Leading, Asia-Pacific Emerging

• North America’s Dominance: In 2023, North America held the largest share in the inhalation anesthesia market. The region’s advanced healthcare infrastructure and ongoing technological innovations contribute to its leadership.
• Asia-Pacific’s Growth: The Asia-Pacific region is anticipated to be the fastest-growing in the forecast period. Increasing healthcare expenditure, a growing number of surgical procedures, and the adoption of inhalation anesthesia in veterinary medicine contribute to the region’s expanding market share.

Conclusion: A Promising Future for Inhalation Anesthesia
As the inhalation anesthesia market continues its upward trajectory, driven by factors such as an aging population, technological advancements, and strategic acquisitions, it presents a promising landscape for healthcare stakeholders. The emphasis on eco-friendly anesthetic agents, technological innovations, and the integration of monitoring technologies further underscores the industry’s commitment to addressing evolving healthcare needs. With North America at the forefront and Asia-Pacific emerging as a key player, the future holds significant opportunities for the inhalation anesthesia market to play a pivotal role in advancing surgical and therapeutic interventions globally.

Request A Sample Of The Global Inhalation Anesthesia Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7198&type=smp